newsfilter
← Latest News
GlobeNewswire·

RVL Pharmaceuticals plc Announces Insider and Athyrium-Led Financing

-- Secured $68.9 million in committed financing through a combination of equity and non-dilutive debt financing -- -- Cash runway anticipated to extend through 2023 with $43.9 million funded at closing and an additional $25.0 million of availability t